Clinical Trial Update: Efficacy and Safety of Lumiracoxib [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lumiracoxib for osteoarthritis reports efficacy and safety results upon completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Lumiracoxib (Lumiracoxib)

Snippet

Sponsor: Novartis | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED